Transdermal permeability of triamcinolone acetonide lipid nanoparticles

Zhenmiao Qin,1 Feng Chen,1,2 Demei Chen,1 Yong Wang,1,2 Yinfeng Tan,1,2 Junfeng Ban3 1School of Pharmacy, Hainan Medical University, Haikou, People’s Republic of China; 2Hainan Provincial Key Laboratory of R&D of Tropical Herbs, Hainan Medical University, Haikou, People’...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qin ZM, Chen F, Chen DM, Wang Y, Tan YF, Ban JF
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/5428ae4d3e234dc1a2665c0032ad7e2b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5428ae4d3e234dc1a2665c0032ad7e2b
record_format dspace
spelling oai:doaj.org-article:5428ae4d3e234dc1a2665c0032ad7e2b2021-12-02T04:50:05ZTransdermal permeability of triamcinolone acetonide lipid nanoparticles1178-2013https://doaj.org/article/5428ae4d3e234dc1a2665c0032ad7e2b2019-04-01T00:00:00Zhttps://www.dovepress.com/transdermal-permeability-of-triamcinolone-acetonide-lipid-nanoparticle-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Zhenmiao Qin,1 Feng Chen,1,2 Demei Chen,1 Yong Wang,1,2 Yinfeng Tan,1,2 Junfeng Ban3 1School of Pharmacy, Hainan Medical University, Haikou, People’s Republic of China; 2Hainan Provincial Key Laboratory of R&D of Tropical Herbs, Hainan Medical University, Haikou, People’s Republic of China; 3Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China Background: Triamcinolone acetonide (TAA) is an effective and the most commonly used corticosteroid hormone for the treatment of hypertrophic scars (HSs). However, the clinically used dosage has poor tissue permeability and injection safety. By contrast, lipid nanoparticles (LNPs) have the advantage of high affinity for the skin.Materials and methods: This article describes the preparation of TAA-LNPs using poly(lactic-co-glycolic acid) as a carrier material, which have good biocompatibility and biodegradability. Based on a systematic investigation of its physicochemical properties, a rabbit ear HSs model was established to evaluate the percutaneous permeability of TAA-LNPs in scar tissue in vitro as well as to assess its curative effect and skin irritation. Results: The results showed that the TAA-LNPs formed uniform and round particles under fluoroscopy and had a complex structure in which a nanoparticle core was surrounded by multiple vesicles. The particles were 232.2±8.2 nm in size, and the complimentary potential was -42.16 mV. The encapsulation efficiency was 85.24%, which is greater than that of other common liposomes and nanoparticles. A test of in vitro scar tissue permeability showed that penetration into scar tissue was twofold and 40-fold higher for TAA-LNPs than for common liposome and commercial suspensions, respectively. The concentration of the absorbed drug effectively inhibited fibroblast proliferation, achieved a therapeutic effect in HSs, and did not stimulate intact or damaged skin. Conclusion: The preparation of TAA into LNPs for transdermal administration can enhance transdermal permeation performance and the safety of this drug, which is beneficial for the treatment of HSs. Keywords: lipid nanoparticles, transdermal permeation, triamcinolone acetonide, hypertrophic scars  Qin ZMChen FChen DMWang YTan YFBan JFDove Medical Pressarticlelipid nanoparticlestransdermal permeationtriamcinolone acetonidehypertrophic scarsMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 2485-2495 (2019)
institution DOAJ
collection DOAJ
language EN
topic lipid nanoparticles
transdermal permeation
triamcinolone acetonide
hypertrophic scars
Medicine (General)
R5-920
spellingShingle lipid nanoparticles
transdermal permeation
triamcinolone acetonide
hypertrophic scars
Medicine (General)
R5-920
Qin ZM
Chen F
Chen DM
Wang Y
Tan YF
Ban JF
Transdermal permeability of triamcinolone acetonide lipid nanoparticles
description Zhenmiao Qin,1 Feng Chen,1,2 Demei Chen,1 Yong Wang,1,2 Yinfeng Tan,1,2 Junfeng Ban3 1School of Pharmacy, Hainan Medical University, Haikou, People’s Republic of China; 2Hainan Provincial Key Laboratory of R&D of Tropical Herbs, Hainan Medical University, Haikou, People’s Republic of China; 3Guangdong Provincial Key Laboratory of Advanced Drug Delivery Systems, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China Background: Triamcinolone acetonide (TAA) is an effective and the most commonly used corticosteroid hormone for the treatment of hypertrophic scars (HSs). However, the clinically used dosage has poor tissue permeability and injection safety. By contrast, lipid nanoparticles (LNPs) have the advantage of high affinity for the skin.Materials and methods: This article describes the preparation of TAA-LNPs using poly(lactic-co-glycolic acid) as a carrier material, which have good biocompatibility and biodegradability. Based on a systematic investigation of its physicochemical properties, a rabbit ear HSs model was established to evaluate the percutaneous permeability of TAA-LNPs in scar tissue in vitro as well as to assess its curative effect and skin irritation. Results: The results showed that the TAA-LNPs formed uniform and round particles under fluoroscopy and had a complex structure in which a nanoparticle core was surrounded by multiple vesicles. The particles were 232.2±8.2 nm in size, and the complimentary potential was -42.16 mV. The encapsulation efficiency was 85.24%, which is greater than that of other common liposomes and nanoparticles. A test of in vitro scar tissue permeability showed that penetration into scar tissue was twofold and 40-fold higher for TAA-LNPs than for common liposome and commercial suspensions, respectively. The concentration of the absorbed drug effectively inhibited fibroblast proliferation, achieved a therapeutic effect in HSs, and did not stimulate intact or damaged skin. Conclusion: The preparation of TAA into LNPs for transdermal administration can enhance transdermal permeation performance and the safety of this drug, which is beneficial for the treatment of HSs. Keywords: lipid nanoparticles, transdermal permeation, triamcinolone acetonide, hypertrophic scars  
format article
author Qin ZM
Chen F
Chen DM
Wang Y
Tan YF
Ban JF
author_facet Qin ZM
Chen F
Chen DM
Wang Y
Tan YF
Ban JF
author_sort Qin ZM
title Transdermal permeability of triamcinolone acetonide lipid nanoparticles
title_short Transdermal permeability of triamcinolone acetonide lipid nanoparticles
title_full Transdermal permeability of triamcinolone acetonide lipid nanoparticles
title_fullStr Transdermal permeability of triamcinolone acetonide lipid nanoparticles
title_full_unstemmed Transdermal permeability of triamcinolone acetonide lipid nanoparticles
title_sort transdermal permeability of triamcinolone acetonide lipid nanoparticles
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/5428ae4d3e234dc1a2665c0032ad7e2b
work_keys_str_mv AT qinzm transdermalpermeabilityoftriamcinoloneacetonidelipidnanoparticles
AT chenf transdermalpermeabilityoftriamcinoloneacetonidelipidnanoparticles
AT chendm transdermalpermeabilityoftriamcinoloneacetonidelipidnanoparticles
AT wangy transdermalpermeabilityoftriamcinoloneacetonidelipidnanoparticles
AT tanyf transdermalpermeabilityoftriamcinoloneacetonidelipidnanoparticles
AT banjf transdermalpermeabilityoftriamcinoloneacetonidelipidnanoparticles
_version_ 1718401004714590208